STRESS PREDICTS TRAJECTORIES OF PSYCHOLOGICAL AND PHYSICAL FUNCTIONING IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

被引:0
|
作者
Goyal, Neha [1 ]
Westbrook, Travis [2 ]
Andersen, Barbara L. [2 ]
机构
[1] VA Palo Alto, Cupertino, CA USA
[2] Ohio State Univ, Columbus, OH 43210 USA
关键词
D O I
暂无
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
D004
引用
下载
收藏
页码:S288 / S288
页数:1
相关论文
共 50 条
  • [1] Cancer-Specific Stress and Trajectories of Psychological and Physical Functioning in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
    Goyal, Neha G.
    Maddocks, Kami J.
    Johnson, Amy J.
    Byrd, John C.
    Westbrook, Travis D.
    Andersen, Barbara L.
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 (04) : 287 - 298
  • [2] The Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia
    Brown, Jennifer R.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 110 - 118
  • [3] Management of relapsed/refractory Chronic Lymphocytic Leukemia
    Woyach, Jennifer A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S11 - S18
  • [4] Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
    Veliz, Marays
    Pinilla-Ibarz, Javier
    CANCER CONTROL, 2012, 19 (01) : 37 - 53
  • [5] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Odetola, Oluwatobi
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 130 - 143
  • [6] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Oluwatobi Odetola
    Shuo Ma
    Current Hematologic Malignancy Reports, 2023, 18 : 130 - 143
  • [7] Management of relapsed/refractory chronic lymphocytic leukemia
    Tomowiak, Cecile
    HEMATOLOGIE, 2024, 30 : 19 - 27
  • [8] Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia
    Abou Zahr, Abdallah
    Bose, Prithviraj
    Keating, Michael J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 857 - 873
  • [9] Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia
    McCune, SL
    Gockerman, JP
    Moore, JO
    Decastro, CM
    Bass, AJ
    Chao, NJ
    Long, GD
    Vredenburgh, JJ
    Gasparetto, C
    Adams, D
    Payne, N
    Rizzieri, DA
    LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 1007 - 1011
  • [10] Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Brown, J. R.
    Eichhorst, B.
    Hillmen, P.
    Jurczak, W.
    Kazmierczak, M.
    Lamanna, N.
    O'Brien, S. M.
    Tam, C. S.
    Qiu, L.
    Zhou, K.
    Simkovic, M.
    Mayer, J.
    Gillespie-Twardy, A.
    Ferrajoli, A.
    Ganly, P. S.
    Weinkove, R.
    Grosicki, S.
    Mital, A.
    Robak, T.
    Osterborg, A.
    Yimer, H. A.
    Salmi, T.
    Wang, M. -D. -Y.
    Fu, L.
    Li, J.
    Wu, K.
    Cohen, A.
    Shadman, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (04): : 319 - 332